Regional Town Hall:

Arizona, Nevada, New Mexico, Texas

Thank you to all who attended CSRO's Regional Town Hall. Presentation slides can be viewed here and the referenced documentation of CSRO's communications with CMS is available on our website. If you have any questions or would like help connecting with your state society, email us at info@csro.info.

We hope you will join us in-person for a national conversation around advocacy in Austin this August for CSRO's annual Advocacy Conference featuring keynote speaker Dr. Alex Oshmyansky, Founder and CEO of Mark Cuban Cost Plus Drug Company – visit our website to learn more and sign up.

RESOURCES

Action Center

• Use CSRO's convenient online platform to easily find out who your elected officials are and engage with them directly.

Advocacy Council

• Amplify your voice by assembling with other like-minded individuals to enhance CSRO’s advocacy initiatives.

Legislative Map Tool

• Find your state on our interactive map tool to learn about current or proposed policy and ways you can take action to make an impact.

Payer Issue Reporting Form

• Request assistance with any payer relation issues that may be impacting your patients or office.

UPCOMING EVENTS

CSRO's Business of Rheumatology Seminar: June 14, 2023

• Learn about ways to expand infusion suite services at the next installment in CSRO's virtual seminar series to help support rheumatology practices.

CSRO Virtual Advocacy Day: July 13, 2023

• Advocate alongside CSRO as we host live conversations with health care leaders from the U.S. Senate and U.S. House of Representatives.

CSRO Advocacy Conference: August 25-27, 2023

• Join us in Austin for our Advocacy Conference featuring keynote speaker Dr. Alex Oshmyansky, Founder and CEO of Mark Cuban Cost Plus Drug Company – plus, don't miss our special 20th Anniversary celebration!

State Society Conferences:

• CSRO's state rheumatology society members host their own annual meetings throughout the year – view a listing of these state conferences on our website.